Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2012

Open Access 01-12-2012 | Database

Text-mining applied to autoimmune disease research: the Sjögren’s syndrome knowledge base

Authors: Sven-Ulrik Gorr, Trevor J Wennblom, Steve Horvath, David TW Wong, Sara A Michie

Published in: BMC Musculoskeletal Disorders | Issue 1/2012

Login to get access

Abstract

Background

Sjögren’s syndrome is a tissue-specific autoimmune disease that affects exocrine tissues, especially salivary glands and lacrimal glands. Despite a large body of evidence gathered over the past 60 years, significant gaps still exist in our understanding of Sjögren’s syndrome. The goal of this study was to develop a database that collects and organizes gene and protein expression data from the existing literature for comparative analysis with future gene expression and proteomic studies of Sjögren’s syndrome.

Description

To catalog the existing knowledge in the field, we used text mining to generate the Sjögren’s Syndrome Knowledge Base (SSKB) of published gene/protein data, which were extracted from PubMed using text mining of over 7,700 abstracts and listing approximately 500 potential genes/proteins. The raw data were manually evaluated to remove duplicates and false-positives and assign gene names. The data base was manually curated to 477 entries, including 377 potential functional genes, which were used for enrichment and pathway analysis using gene ontology and KEGG pathway analysis.

Conclusions

The Sjögren’s syndrome knowledge base (http://​sskb.​umn.​edu) can form the foundation for an informed search of existing knowledge in the field as new potential therapeutic targets are identified by conventional or high throughput experimental techniques.
Literature
1.
go back to reference Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, Bootsma H: Health-related quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology. 2009, 48 (9): 1077-1082. 10.1093/rheumatology/kep141.CrossRefPubMed Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, Bootsma H: Health-related quality of life, employment and disability in patients with Sjogren's syndrome. Rheumatology. 2009, 48 (9): 1077-1082. 10.1093/rheumatology/kep141.CrossRefPubMed
2.
go back to reference Rhodus NL: Sjogren's syndrome. Quintessence Int. 1999, 30 (10): 689-699.PubMed Rhodus NL: Sjogren's syndrome. Quintessence Int. 1999, 30 (10): 689-699.PubMed
3.
go back to reference Williams PH, Cobb BL, Namjou B, Scofield RH, Sawalha AH, Harley JB: Horizons in Sjogren's syndrome genetics. Clin Rev Allergy Immunol. 2007, 32 (3): 201-209. 10.1007/s12016-007-8002-9.CrossRefPubMedPubMedCentral Williams PH, Cobb BL, Namjou B, Scofield RH, Sawalha AH, Harley JB: Horizons in Sjogren's syndrome genetics. Clin Rev Allergy Immunol. 2007, 32 (3): 201-209. 10.1007/s12016-007-8002-9.CrossRefPubMedPubMedCentral
4.
5.
go back to reference Mavragani CP, Crow MK: Activation of the type I interferon pathway in primary Sjogren's syndrome. J Autoimmun. 2010, 35 (3): 225-231. 10.1016/j.jaut.2010.06.012.CrossRefPubMed Mavragani CP, Crow MK: Activation of the type I interferon pathway in primary Sjogren's syndrome. J Autoimmun. 2010, 35 (3): 225-231. 10.1016/j.jaut.2010.06.012.CrossRefPubMed
6.
go back to reference Peck AB, Nguyen CQ, Sharma A, McIndoe RA, She JX: The Interferon-Signature of Sjögren's Syndrome: What does It say about the etiopathology of autoimmunity?. J Clin Rheumatol Musculoskel Med. 2011, 3 (1): Peck AB, Nguyen CQ, Sharma A, McIndoe RA, She JX: The Interferon-Signature of Sjögren's Syndrome: What does It say about the etiopathology of autoimmunity?. J Clin Rheumatol Musculoskel Med. 2011, 3 (1):
7.
go back to reference Rosen A, Casciola-Rosen L: Altered autoantigen structure in Sjogren's syndrome: implications for the pathogenesis of autoimmune tissue damage. Crit Rev Oral Biol Med. 2004, 15 (3): 156-164. 10.1177/154411130401500304.CrossRefPubMed Rosen A, Casciola-Rosen L: Altered autoantigen structure in Sjogren's syndrome: implications for the pathogenesis of autoimmune tissue damage. Crit Rev Oral Biol Med. 2004, 15 (3): 156-164. 10.1177/154411130401500304.CrossRefPubMed
8.
go back to reference Stathopoulou EA, Routsias JG, Stea EA, Moutsopoulos HM, Tzioufas AG: Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein. Clin Exp Immunol. 2005, 141 (1): 148-154. 10.1111/j.1365-2249.2005.02812.x.CrossRefPubMedPubMedCentral Stathopoulou EA, Routsias JG, Stea EA, Moutsopoulos HM, Tzioufas AG: Cross-reaction between antibodies to the major epitope of Ro60 kD autoantigen and a homologous peptide of Coxsackie virus 2B protein. Clin Exp Immunol. 2005, 141 (1): 148-154. 10.1111/j.1365-2249.2005.02812.x.CrossRefPubMedPubMedCentral
9.
go back to reference Zhao Z-S, Granucci F, Yeh L, Schaffer PA, Cantor H: Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 1998, 279 (5355): 1344-1347. 10.1126/science.279.5355.1344.CrossRefPubMed Zhao Z-S, Granucci F, Yeh L, Schaffer PA, Cantor H: Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 1998, 279 (5355): 1344-1347. 10.1126/science.279.5355.1344.CrossRefPubMed
10.
go back to reference Nguyen KH, Brayer J, Cha S, Diggs S, Yasunari U, Hilal G, Peck AB, Humphreys-Beher MG: Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice. Arthritis Rheum. 2000, 43 (10): 2297-2306. 10.1002/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X.CrossRefPubMed Nguyen KH, Brayer J, Cha S, Diggs S, Yasunari U, Hilal G, Peck AB, Humphreys-Beher MG: Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice. Arthritis Rheum. 2000, 43 (10): 2297-2306. 10.1002/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X.CrossRefPubMed
11.
go back to reference Li J, Ha Y, Ku N, Choi S, Lee S, Oh S, Kim J, Lee J, Lee E, Song Y, et al.: Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren's syndrome. Lab Invest. 2004, 84 (11): 1430-1438. 10.1038/labinvest.3700173.CrossRefPubMed Li J, Ha Y, Ku N, Choi S, Lee S, Oh S, Kim J, Lee J, Lee E, Song Y, et al.: Inhibitory effects of autoantibodies on the muscarinic receptors in Sjogren's syndrome. Lab Invest. 2004, 84 (11): 1430-1438. 10.1038/labinvest.3700173.CrossRefPubMed
12.
go back to reference von Bultzingslöwen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, Wray D, Brennan MT, Carrozzo M, Gandera B, et al.: Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 103 (Suppl): S75.e1-e15.- von Bultzingslöwen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, Wray D, Brennan MT, Carrozzo M, Gandera B, et al.: Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 103 (Suppl): S75.e1-e15.-
13.
go back to reference Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H: Effectiveness of rituximab treatment in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010, 62 (4): 960-968. 10.1002/art.27314.CrossRefPubMed Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, Brouwer E, Kallenberg CG, Bootsma H: Effectiveness of rituximab treatment in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010, 62 (4): 960-968. 10.1002/art.27314.CrossRefPubMed
14.
go back to reference Moutsopoulos NM, Katsifis GE, Angelov N, Leakan RA, Sankar V, Pillemer S, Wahl SM: Lack of efficacy of etanercept in Sjogren's syndrome correlates with failed suppression of TNF{alpha} and systemic immune activation. Ann Rheum Dis. 2008, 67 (10): 1437-1443. 10.1136/ard.2007.077891.CrossRefPubMed Moutsopoulos NM, Katsifis GE, Angelov N, Leakan RA, Sankar V, Pillemer S, Wahl SM: Lack of efficacy of etanercept in Sjogren's syndrome correlates with failed suppression of TNF{alpha} and systemic immune activation. Ann Rheum Dis. 2008, 67 (10): 1437-1443. 10.1136/ard.2007.077891.CrossRefPubMed
15.
go back to reference Gottenberg J-E, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, et al.: Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci U S A. 2006, 103 (8): 2770-2775. 10.1073/pnas.0510837103.CrossRefPubMedPubMedCentral Gottenberg J-E, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, et al.: Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci U S A. 2006, 103 (8): 2770-2775. 10.1073/pnas.0510837103.CrossRefPubMedPubMedCentral
16.
go back to reference Hu S, Zhou M, Jiang J, Wang J, Elashoff D, Gorr S, Michie SA, Spijkervet FK, Bootsma H, Kallenberg CG, et al.: Systems biology analysis of Sjogren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. Arthritis Rheum. 2009, 60 (1): 81-92. 10.1002/art.24150.CrossRefPubMedPubMedCentral Hu S, Zhou M, Jiang J, Wang J, Elashoff D, Gorr S, Michie SA, Spijkervet FK, Bootsma H, Kallenberg CG, et al.: Systems biology analysis of Sjogren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. Arthritis Rheum. 2009, 60 (1): 81-92. 10.1002/art.24150.CrossRefPubMedPubMedCentral
17.
go back to reference Nguyen CQ, Sharma A, Lee BH, She JX, McIndoe RA, Peck AB: Differential gene expression in the salivary gland during development and onset of xerostomia in Sjogren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. Arthritis Res Ther. 2009, 11 (2): R56-10.1186/ar2676.CrossRefPubMedPubMedCentral Nguyen CQ, Sharma A, Lee BH, She JX, McIndoe RA, Peck AB: Differential gene expression in the salivary gland during development and onset of xerostomia in Sjogren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse. Arthritis Res Ther. 2009, 11 (2): R56-10.1186/ar2676.CrossRefPubMedPubMedCentral
20.
go back to reference Rebholz-Schuhmann D, Kirsch H, Arregui M, Gaudan S, Riethoven M, Stoehr P: EBIMed—text crunching to gather facts for proteins from Medline. Bioinformatics. 2007, 23 (2): e237-e244. 10.1093/bioinformatics/btl302.CrossRefPubMed Rebholz-Schuhmann D, Kirsch H, Arregui M, Gaudan S, Riethoven M, Stoehr P: EBIMed—text crunching to gather facts for proteins from Medline. Bioinformatics. 2007, 23 (2): e237-e244. 10.1093/bioinformatics/btl302.CrossRefPubMed
23.
go back to reference Consortium TU: Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res. 2011, 39 (suppl 1): D214-D219.CrossRef Consortium TU: Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res. 2011, 39 (suppl 1): D214-D219.CrossRef
25.
go back to reference Zhang B, Kirov S, Snoddy J: WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic acids research. 2005, 33 (Web Server issue): W741-W748.CrossRefPubMedPubMedCentral Zhang B, Kirov S, Snoddy J: WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic acids research. 2005, 33 (Web Server issue): W741-W748.CrossRefPubMedPubMedCentral
26.
go back to reference Benjamini Y, Hochberg Y: Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met. 1995, 57 (1): 289-300. Benjamini Y, Hochberg Y: Controlling the false discovery rate - a practical and powerful approach to multiple testing. J Roy Stat Soc B Met. 1995, 57 (1): 289-300.
28.
go back to reference Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al.: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000, 25 (1): 25-29. 10.1038/75556.CrossRefPubMedPubMedCentral Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al.: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000, 25 (1): 25-29. 10.1038/75556.CrossRefPubMedPubMedCentral
31.
go back to reference Nguyen CQ, Peck AB: Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf. 2009, 7 (1): 11-27. 10.1016/S1542-0124(12)70289-6.CrossRefPubMedPubMedCentral Nguyen CQ, Peck AB: Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf. 2009, 7 (1): 11-27. 10.1016/S1542-0124(12)70289-6.CrossRefPubMedPubMedCentral
32.
go back to reference Mariette X, Gottenberg JE: Pathogenesis of Sjogren's syndrome and therapeutic consequences. Curr Opin Rheumatol. 2010, 22 (5): 471-477. 10.1097/BOR.0b013e32833c36c5.CrossRefPubMed Mariette X, Gottenberg JE: Pathogenesis of Sjogren's syndrome and therapeutic consequences. Curr Opin Rheumatol. 2010, 22 (5): 471-477. 10.1097/BOR.0b013e32833c36c5.CrossRefPubMed
33.
go back to reference Sall K, Stevenson OD, Mundorf TK, Reis BL: Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000, 107 (4): 631-639. 10.1016/S0161-6420(99)00176-1.CrossRefPubMed Sall K, Stevenson OD, Mundorf TK, Reis BL: Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000, 107 (4): 631-639. 10.1016/S0161-6420(99)00176-1.CrossRefPubMed
34.
go back to reference Oxholm P, Winther K, Manthorpe R: Platelets in blood and salivary glands of patients with primary Sjogren's syndrome. Scand J Rheumatol Suppl. 1986, 61: 170-172.PubMed Oxholm P, Winther K, Manthorpe R: Platelets in blood and salivary glands of patients with primary Sjogren's syndrome. Scand J Rheumatol Suppl. 1986, 61: 170-172.PubMed
35.
go back to reference Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR: Serum lipid levels in Sjögren's syndrome. Rheumatology. 2006, 45 (4): 481-484. 10.1093/rheumatology/kei190.CrossRefPubMed Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR: Serum lipid levels in Sjögren's syndrome. Rheumatology. 2006, 45 (4): 481-484. 10.1093/rheumatology/kei190.CrossRefPubMed
36.
go back to reference Ostrowski RA, Robinson JA: Antiphospholipid antibody syndrome and autoimmune diseases. Hematol Oncol Clin North Am. 2008, 22 (1): 53-65. 10.1016/j.hoc.2007.10.003.CrossRefPubMed Ostrowski RA, Robinson JA: Antiphospholipid antibody syndrome and autoimmune diseases. Hematol Oncol Clin North Am. 2008, 22 (1): 53-65. 10.1016/j.hoc.2007.10.003.CrossRefPubMed
37.
go back to reference Chai J, Logigian EL: Neurological manifestations of primary Sjogren's syndrome. Curr Opin Neurol. 2010, 23 (5): 509-513. 10.1097/WCO.0b013e32833de6ab.CrossRefPubMed Chai J, Logigian EL: Neurological manifestations of primary Sjogren's syndrome. Curr Opin Neurol. 2010, 23 (5): 509-513. 10.1097/WCO.0b013e32833de6ab.CrossRefPubMed
38.
go back to reference Caulfield VL, Balmer C, Dawson LJ, Smith PM: A role for nitric oxide-mediated glandular hypofunction in a non-apoptotic model for Sjogren's syndrome. Rheumatology. 2009, 48 (7): 727-733. 10.1093/rheumatology/kep100.CrossRefPubMed Caulfield VL, Balmer C, Dawson LJ, Smith PM: A role for nitric oxide-mediated glandular hypofunction in a non-apoptotic model for Sjogren's syndrome. Rheumatology. 2009, 48 (7): 727-733. 10.1093/rheumatology/kep100.CrossRefPubMed
Metadata
Title
Text-mining applied to autoimmune disease research: the Sjögren’s syndrome knowledge base
Authors
Sven-Ulrik Gorr
Trevor J Wennblom
Steve Horvath
David TW Wong
Sara A Michie
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2012
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-13-119

Other articles of this Issue 1/2012

BMC Musculoskeletal Disorders 1/2012 Go to the issue